Stockscreener 앱 받기
2.29
2.23%
0.05
전일 마감가:
$2.24
열려 있는:
$2.2
하루 거래량:
863.59K
Relative Volume:
1.17
시가총액:
$331.99M
수익:
$28.94M
순이익/손실:
$-54.29M
주가수익비율:
-4.9279
EPS:
-0.4647
순현금흐름:
$-26.02M
1주 성능:
-5.37%
1개월 성능:
-3.78%
6개월 성능:
+19.90%
1년 성능:
+11.17%
1일 변동 폭
$2.14
$2.35
1주일 범위
$2.14
$2.57
52주 변동 폭
$1.30
$2.79
Omniab Inc Stock (OABI) Company Profile
명칭
Omniab Inc
전화
510-250-7800
주소
5980 HORTON STREET, EMERYVILLE
Compare OABI vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
2.29 | 331.99M | 28.94M | -54.29M | -26.02M | -0.4647 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-04-21 | 개시 | The Benchmark Company | Buy |
| 2023-04-13 | 개시 | Craig Hallum | Buy |
| 2023-02-22 | 개시 | Cowen | Outperform |
| 2023-02-13 | 개시 | H.C. Wainwright | Buy |
| 2022-12-20 | 개시 | Truist | Buy |
| 2022-12-16 | 개시 | Credit Suisse | Outperform |
| 2022-11-29 | 개시 | SVB Leerink | Outperform |
| 2022-11-28 | 개시 | Stifel | Buy |
모두보기
Omniab Inc 주식(OABI)의 최신 뉴스
OmniAb (OABI) Edges Lower Amid Quiet Trading – Support Levels in FocusLow Volume Node - dars.gov.et
OABI,VKTX Revenue Breakdown - Finviz
VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines - GlobeNewswire Inc.
OmniAb Inc. (OABI) Edges Higher, Testing Key Resistance ZoneMomentum Breakout Ideas - dars.gov.et
OmniAb (OABI) Price Target Decreased by 13.73% to 7.48 - MSN
OABIOmniAb Inc Volatility & Greeks - Finviz
OmniAb (OABI) Gains More Than 38% Over 6 Months, Can It Go Higher? - Yahoo Finance
OmniAb, Inc. Warrant 2022- on Omniab Inc Financial Disclosures & SEC Filings - TradingView
OmniAb, Inc. Financial Disclosures & SEC Filings - TradingView
OmniAb (NASDAQ:OABI) Cash Burn Looks Manageable - Kalkine Media
Sparrow Highlights Client Use of Leave Management Platform for Complex California Compliance - TipRanks
Earnings Preview: OmniAb to Report Financial Results Post-market on May 07 - Moomoo
OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 2000 Growth Benchmark - marketscreener.com
OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 3000E Growth Benchmark - marketscreener.com
OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 3000 Growth Benchmark - marketscreener.com
OmniAb, Inc. Actuals & Estimates (NASDAQ:OABI) - TradingView
OABI Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of OmniAb, Inc. – BOATS:OABIW - TradingView
Price to book forward of OmniAb, Inc. – BOATS:OABIW - TradingView
Enterprise value to revenue forward of OmniAb, Inc. – BOATS:OABIW - TradingView
OmniAb Inc. (OABI) Surges Over 10% as Stock Tests Key ResistanceShort Term Trading Ideas - dars.gov.et
OmniAb Inc (OABIW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OmniAb Inc (OABIW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OmniAb Inc. (OABI) Consolidates Near Key Support Level Amid Modest UptickDescending Triangle - dars.gov.et
OmniAb shareholders elect directors and ratify auditor at annual meeting By Investing.com - Investing.com Australia
OmniAb shareholders elect directors and ratify auditor at annual meeting - Investing.com UK
OmniAb Shareholders Approve Directors and Auditor at Meeting - TipRanks
OmniAb (OABI) director Bertozzi exercises RSUs and receives new option, RSU grants - Stock Titan
OmniAb (OABI) director adds shares through RSU vesting and new equity grants - Stock Titan
OmniAb (OABI) director receives options and RSUs, exercises 20,000 shares - Stock Titan
OmniAb (OABI) director granted stock options and RSUs - Stock Titan
OmniAb (OABI) director adds options and RSUs in Form 4 filing - Stock Titan
OmniAb (OABI) director gains stock, options and RSUs in Form 4 - Stock Titan
OmniAb (OABI) 2026 annual meeting elects directors and ratifies auditor - Stock Titan
OmniAb Inc (OABIW) Institutional Confidence - TradingKey
OmniAb Inc (OABIW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OmniAb Inc (OABI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Why Is OmniAb Gaining Attention In The Biotechnology Landscape? - Kalkine Media
OmniAb Inc (OABI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OmniAb Inc (OABI) Institutional Confidence - TradingKey
OmniAb Inc (OABI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OmniAb Inc (OABI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OmniAb Inc (OABI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OmniAb Inc (OABIW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OmniAb Inc (OABIW) Valuation: PE, PB & Fair Value Analysis - TradingKey
OmniAb Inc (OABI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OmniAb Inc (OABI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OmniAb Inc (OABI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OmniAb Inc (OABIW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OmniAb Inc (OABIW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Omniab Inc (OABI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
자본화:
|
볼륨(24시간):